Absolutely 100% correct.
True, true, true, true and TRUE!
I really really wish people would think in particular about point 3. It's crucial to understand this.
If we go ahead and sell battery tech, and keep ADO tech, we'll be taking defeat from the jaws of victory.
I think GC fails to understand that he had the weight of Roche behind him when he was a salesman there.
A new pathology company has to run the gauntlet of existing companies with existing tests, and those existing companies have cosy agreements which involve kickbacks (eg. cruises to doctors who use such and such company, or trips to exotic locations for conferences, or other freebies). This has been the subject of investigations by journalists, and I think a 4 corners program. It's why they don't care about higher diagnostic accuracy. Nobody wants to rock the boat. It's working just fine...for them!
This is the real commercial world, not fantasyland.
The odd thing is, people refuse to join the dots. Denial is just so psychologically powerful.
- Forums
- ASX - By Stock
- ADO
- Ann: Anteo Shareholder Presentation Times
Ann: Anteo Shareholder Presentation Times, page-36
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ADO (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $52.28M |
Open | High | Low | Value | Volume |
2.1¢ | 2.2¢ | 2.0¢ | $12.51K | 612.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 1790998 | 2.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.1¢ | 32423 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 1790998 | 0.020 |
8 | 1727381 | 0.019 |
4 | 468115 | 0.018 |
2 | 64748 | 0.017 |
1 | 420000 | 0.016 |
Price($) | Vol. | No. |
---|---|---|
0.022 | 700616 | 2 |
0.023 | 322844 | 5 |
0.024 | 741966 | 3 |
0.025 | 1118820 | 11 |
0.026 | 291415 | 3 |
Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
Featured News
ADO (ASX) Chart |